tiprankstipranks
Shanghai Pharmaceuticals Holding Co Ltd Class H (SHPMF)
OTHER OTC:SHPMF
US Market
SHPMF
Shanghai Pharmaceuticals Holding Co
RESEARCH TOOLSreports
Want to see SHPMF full AI Analyst Report?

Shanghai Pharmaceuticals Holding Co (SHPMF) Income Statement

12 Followers

Shanghai Pharmaceuticals Holding Co Income Statement

Last quarter (Q1 2026), Shanghai Pharmaceuticals Holding Co's total revenue was ¥74.58B, an increase of 5.40% from the same quarter last year. In Q1, Shanghai Pharmaceuticals Holding Co's net income was ¥1.40B. See Shanghai Pharmaceuticals Holding Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 283.58B¥ 275.25B¥ 260.30B¥ 231.98B¥ 215.82B
Gross Profit
¥ 30.42B¥ 30.63B¥ 30.93B¥ 30.49B¥ 28.54B
Operating Expenses
¥ 20.47B¥ 22.49B¥ 23.26B¥ 21.71B¥ 20.62B
Depreciation and Amortization
¥ 2.86B¥ 2.42B¥ 2.19B¥ 2.22B¥ 2.14B
EBITDA
¥ 14.37B¥ 12.06B¥ 10.90B¥ 12.44B¥ 10.55B
Operating Income
¥ 9.94B¥ 8.14B¥ 7.67B¥ 9.01B¥ 8.21B
Other Income/Expenses
¥ -122.28M¥ -120.71M¥ -612.94M¥ -206.30M¥ -61.67M
Pretax Income
¥ 9.82B¥ 8.02B¥ 7.05B¥ 8.81B¥ 8.14B
Net Income
¥ 5.72B¥ 4.55B¥ 3.77B¥ 5.62B¥ 5.09B
Per Share Metrics
Basic EPS
¥ 1.54¥ 1.23¥ 1.02¥ 1.61¥ 1.79
Diluted EPS
¥ 1.54¥ 1.23¥ 1.02¥ 1.61¥ 1.79
Weighted Average Shares Outstanding
 3.71B 3.70B 3.70B 3.48B 2.84B
Weighted Average Shares Outstanding (Diluted)
 3.71B 3.70B 3.70B 3.49B 2.85B
Currency in CNY

Shanghai Pharmaceuticals Holding Co Earnings and Revenue History